Catherine Cusack Buys 1,000 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack acquired 1,000 shares of Sabra Health Care REIT stock in a transaction dated Friday, February 21st. The shares were acquired at an average cost of $16.43 per share, with a total value of $16,430.00. Following the completion of the acquisition, the director now directly owns 59,083 shares in the company, valued at $970,733.69. This trade represents a 1.72 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link.

Catherine Cusack also recently made the following trade(s):

• On Monday, February 24th, Catherine Cusack purchased 1,500 shares of Sabra Health Care REIT stock. The stock was acquired at an average cost of $15.92 per share, with a total value of $23,880.00.

Sabra Health Care REIT Trading Down 0.2 %

Shares of SBRA opened at $16.39 on Thursday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The company has a market cap of $3.90 billion, a price-to-earnings ratio of 30.93, a PEG ratio of 1.97 and a beta of 1.25. The stock has a fifty day moving average price of $16.78 and a two-hundred day moving average price of $17.62. Sabra Health Care REIT, Inc. has a 52-week low of $13.31 and a 52-week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. The business had revenue of $182.35 million during the quarter, compared to analysts’ expectations of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. Analysts predict that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.32%. The ex-dividend date is Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio is presently 226.42%.

Wall Street Analysts Forecast Growth

SBRA has been the topic of a number of recent research reports. Mizuho reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research note on Tuesday, January 7th. Finally, Truist Financial downgraded shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their target price for the company from $18.00 to $17.00 in a research note on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $18.86.

Institutional Trading of Sabra Health Care REIT

Several hedge funds have recently modified their holdings of SBRA. Geode Capital Management LLC raised its position in Sabra Health Care REIT by 1.7% in the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock worth $117,165,000 after purchasing an additional 104,533 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Sabra Health Care REIT by 222.4% during the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock worth $183,996,000 after acquiring an additional 6,819,919 shares during the last quarter. Vestcor Inc lifted its stake in shares of Sabra Health Care REIT by 62.5% during the third quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock valued at $3,869,000 after acquiring an additional 79,956 shares during the period. Barclays PLC boosted its holdings in Sabra Health Care REIT by 56.1% in the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock valued at $12,624,000 after acquiring an additional 243,895 shares during the last quarter. Finally, Franklin Resources Inc. increased its position in Sabra Health Care REIT by 12.3% in the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock worth $9,543,000 after purchasing an additional 57,551 shares during the period. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.